Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India
Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )
7 Sep 2024

Colon cancer and mental health

Prof V Surendran- Cancer Institute, Chennai, India
Colon cancer and mental health ( Prof V Surendran- Cancer Institute, Chennai, India )
7 Sep 2024

Linvoseltamab can be a potentially effective treatment option for patients with relapsed/refractory multiple myeloma

Dr Suzanne Lentzsch - Columbia University, New York, USA
Linvoseltamab can be a potentially effective treatment option for patients with relapsed/refractory multiple myeloma ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
22 Aug 2024

Positive data for the use of radioligand therapy in first-line neuroendocrine cancers

Dr Simron Singh - University of Toronto, Toronto, Canada
Positive data for the use of radioligand therapy in first-line neuroendocrine cancers ( Dr Simron Singh - University of Toronto, Toronto, Canada )
21 Aug 2024

Multiple myeloma In Rwanda: The need for further research

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )
6 Aug 2024

Durable responses in aRCC, how do we optimise treatment?

Prof Roberto Iacovelli and Prof Viktor Grünwald
Durable responses in aRCC, how do we optimise treatment? ( Prof Roberto Iacovelli and Prof Viktor Grünwald )
30 Jul 2024

Perspectives on advance care planning for advanced cancer in the Philippines

Dr Sachiko Estreller - Cordillera Hospital of the Divine Grace, Benguet, Philippines
Perspectives on advance care planning for advanced cancer in the Philippines ( Dr Sachiko Estreller - Cordillera Hospital of the Divine Grace, Benguet, Philippines )
29 Jul 2024

The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC

Dr Francesco Sclafani - Institut Jules Bordet, Brussels, Belgium
The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC ( Dr Francesco Sclafani - Institut Jules Bordet, Brussels, Belgium )
25 Jul 2024

Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC

Prof Michel Ducreux - Gustave Roussy Cancer Centre, Paris, France
Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC ( Prof Michel Ducreux - Gustave Roussy Cancer Centre, Paris, France )
24 Jul 2024

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients

Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients ( Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea )
15 Jul 2024

Biomarkers, predictive and prognostic factors of resistance to immunotherapy

Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain
Biomarkers, predictive and prognostic factors of resistance to immunotherapy ( Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain )
12 Jul 2024

Research highlights in gastrointestinal tumours

Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA
Research highlights in gastrointestinal tumours ( Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA )
12 Jul 2024